Cannabis biotech startup Avicanna raises $1.6 mln in funding
Avicanna Inc, a biotechnology startup focused on the medical cannabis industry, recently secured $1.6 million in seed-stage financing. The investors in the round were not disclosed. Launched in 2016, Toronto-based Avicanna said the funds raised will allow the company to execute on its business plan, including the clinical development of its primary product line, PURA Elements, a cannabinoid delivery system. Avicanna, which is led by CEO Aras Azadian, also announced its acceptance as a resident in the Johnson & Johnson Innovation-backed JLABS incubator at MaRS Discovery District.
29 May 2017•3 mins read
